Abbott ABT Derivative Assets - Designated as Hedging Instruments
Derivative Assets - Designated as Hedging Instruments at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue.
The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Abbott's derivative assets - designated as hedging instruments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Abbott's derivative assets - designated as hedging instruments?
- Abbott (ABT) reported derivative assets - designated as hedging instruments of $240M in Q1 2026.
- What does derivative assets - designated as hedging instruments mean?
- This represents the fair value of derivative financial instruments that the company has specifically designated as hedging instruments to mitigate risks such as foreign exchange, interest rate, or commodity price volatility. These assets are recorded on the balance sheet to reflect the economic benefit of the hedge. It provides insight into the company's risk management effectiveness and exposure to market fluctuations.